NHC RSI Chart
Last 7 days
4.3%
Last 30 days
-1.9%
Last 90 days
-6.5%
Trailing 12 Months
58.0%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 1.1B | 1.1B | 1.1B | 1.1B |
2022 | 1.1B | 1.1B | 1.1B | 1.1B |
2021 | 1.0B | 1.0B | 1.1B | 1.1B |
2020 | 1.0B | 1.0B | 1.0B | 1.0B |
2019 | 985.7M | 990.7M | 991.4M | 996.4M |
2018 | 969.2M | 972.6M | 977.7M | 980.3M |
2017 | 935.6M | 946.5M | 956.4M | 964.7M |
2016 | 913.8M | 916.7M | 922.6M | 926.6M |
2015 | 883.6M | 891.9M | 899.1M | 906.6M |
2014 | 805.1M | 829.7M | 852.1M | 871.7M |
2013 | 765.3M | 769.7M | 776.1M | 789.0M |
2012 | 770.6M | 767.5M | 759.8M | 761.0M |
2011 | 740.3M | 754.1M | 772.7M | 773.5M |
2010 | 0 | 689.0M | 704.8M | 720.7M |
2009 | 0 | 0 | 0 | 673.2M |
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index
Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>
Returns of $10,000 invested in:
Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224
Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 12, 2024 | flatt ben anderson sr | acquired | 201,358 | 53.94 | 3,733 | senior vp & cio |
Mar 12, 2024 | dodson vicki l | acquired | 201,358 | 53.94 | 3,733 | sr.vp patient srvcs |
Mar 12, 2024 | dodson vicki l | sold (taxes) | -252,778 | 96.48 | -2,620 | sr.vp patient srvcs |
Mar 12, 2024 | mcintosh leroy e. jr. | sold (taxes) | -252,778 | 96.48 | -2,620 | svp, anc srvcs & srvc strategy |
Mar 12, 2024 | mcintosh leroy e. jr. | acquired | 201,358 | 53.94 | 3,733 | svp, anc srvcs & srvc strategy |
Mar 12, 2024 | kidd brian f | sold (taxes) | -270,819 | 96.48 | -2,807 | svp, controller, pao |
Mar 12, 2024 | flatt ben anderson sr | sold (taxes) | -252,778 | 96.48 | -2,620 | senior vp & cio |
Mar 12, 2024 | flatt stephen fowler | acquired | 134,850 | 53.94 | 2,500 | ceo |
Mar 12, 2024 | flatt stephen fowler | sold (taxes) | -174,629 | 96.48 | -1,810 | ceo |
Mar 12, 2024 | ussery robert michael | acquired | 242,730 | 53.94 | 4,500 | president & coo |
Which funds bought or sold NHC recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Apr 23, 2024 | REGIONS FINANCIAL CORP | sold off | -100 | -336,409 | - | -% |
Apr 23, 2024 | Louisiana State Employees Retirement System | unchanged | - | 14,003 | 633,217 | 0.01% |
Apr 23, 2024 | AMALGAMATED BANK | reduced | -13.64 | -54,000 | 406,000 | -% |
Apr 22, 2024 | MetLife Investment Management, LLC | unchanged | - | 188,244 | 611,728 | -% |
Apr 19, 2024 | DENALI ADVISORS LLC | sold off | -100 | -1,700,530 | - | -% |
Apr 19, 2024 | Maryland State Retirement & Pension System | unchanged | - | -25,460 | 427,490 | 0.01% |
Apr 19, 2024 | State of Alaska, Department of Revenue | reduced | -0.96 | 10,000 | 776,000 | 0.01% |
Apr 19, 2024 | Copeland Capital Management, LLC | added | 0.61 | 877 | 31,283 | -% |
Apr 18, 2024 | Allspring Global Investments Holdings, LLC | added | 28.05 | 463,306 | 1,960,230 | -% |
Apr 18, 2024 | FARMERS & MERCHANTS INVESTMENTS INC | unchanged | - | 17.00 | 756 | -% |
Unveiling National HealthCare Corp's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to National HealthCare Corp)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 449.3B | 371.6B | 20.08 | 1.21 | ||||
CI | 103.0B | 195.3B | 19.17 | 0.53 | ||||
CVS | 85.3B | 357.8B | 10.21 | 0.24 | ||||
HCA | 84.4B | 65.0B | 16.11 | 1.3 | ||||
CNC | 40.8B | 154.0B | 15.09 | 0.26 | ||||
DVA | 11.6B | 12.1B | 16.83 | 0.96 | ||||
UHS | 11.5B | 14.3B | 16.03 | 0.81 | ||||
MID-CAP | ||||||||
CHE | 9.3B | 2.3B | 34.26 | 4.12 | ||||
ACHC | 6.5B | 2.9B | -301.31 | 2.23 | ||||
AMN | 2.2B | 3.8B | 10.28 | 0.57 | ||||
AMEH | 2.1B | 1.4B | 33.83 | 1.48 | ||||
SMALL-CAP | ||||||||
ADUS | 1.5B | 1.1B | 24.79 | 1.46 | ||||
BKD | 1.3B | 3.0B | -6.76 | 0.42 | ||||
BEAT | 53.7M | - | -3.67 | - | ||||
AMS | 18.7M | 21.3M | 35.15 | 0.88 |
National HealthCare Corp News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Revenue | 4.3% | 301 | 288 | 283 | 270 | 265 | 271 | 271 | 279 | 283 | 277 | 263 | 251 | 260 | 251 | 262 | 256 | 254 | 247 | 247 | 248 | 249 |
Costs and Expenses | 1.9% | 281 | 275 | 269 | 260 | 256 | 267 | 267 | 265 | 274 | 264 | 249 | 236 | 247 | 244 | 249 | 240 | 237 | 240 | 237 | 233 | 232 |
Interest Expenses | -27.3% | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Income Taxes | 122.6% | 9.00 | 4.00 | 6.00 | 4.00 | 2.00 | -1.14 | 1.00 | 5.00 | 5.00 | -4.09 | 3.00 | 7.00 | 10.00 | 0.00 | 10.00 | -9.62 | 5.00 | 3.00 | 5.00 | 7.00 | 6.00 |
Net Income | 177.3% | 29.00 | 10.00 | 16.00 | 11.00 | 7.00 | -2.43 | 2.00 | 15.00 | 16.00 | -3.35 | 105 | 21.00 | 27.00 | 13.00 | 29.00 | -26.82 | 14.00 | 19.00 | 14.00 | 21.00 | 18.00 |
Net Income Margin | 44.6% | 0.06* | 0.04* | 0.03* | 0.02* | 0.02* | 0.03* | 0.03* | 0.12* | 0.13* | 0.14* | 0.16* | 0.09* | - | - | - | - | - | - | - | - | - |
Free Cashflow | -33.6% | 17.00 | 26.00 | 33.00 | 7.00 | 6.00 | -9.51 | 18.00 | -36.42 | 2.00 | -5.88 | 19.00 | 8.00 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | 2.3% | 1,311 | 1,282 | 1,281 | 1,265 | 1,275 | 1,296 | 1,350 | 1,357 | 1,403 | 1,416 | 1,457 | 1,355 | 1,362 | 1,339 | 1,335 | 1,256 | 1,287 | 1,307 | 1,315 | 1,312 | 1,081 |
Current Assets | 6.2% | 406 | 383 | 369 | 338 | 354 | 345 | 395 | 384 | 427 | 425 | 466 | 465 | 457 | 422 | 390 | 307 | 341 | 351 | 322 | 327 | 18.00 |
Cash Equivalents | 6.7% | 107 | 100 | 78.00 | 46.00 | 59.00 | 45.00 | 76.00 | 57.00 | 108 | 112 | 135 | 134 | 147 | 184 | 149 | 69.00 | 50.00 | 59.00 | 30.00 | 38.00 | 43.00 |
Inventory | 0.2% | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 7.00 | 9.00 | 9.00 | 9.00 | 8.00 | 8.00 | 9.00 | 7.00 | 7.00 | 8.00 | 7.00 | 8.00 | 7.00 | 7.00 | 7.00 |
Net PPE | -1.0% | 493 | 498 | 502 | 503 | 507 | 511 | 516 | 520 | 521 | 522 | 520 | 514 | 520 | 531 | 536 | 541 | 535 | 540 | 545 | 533 | 535 |
Goodwill | 0% | 168 | 168 | 168 | 168 | 168 | 168 | 168 | 168 | 168 | 168 | 168 | 168 | 21.00 | 21.00 | 21.00 | 21.00 | 21.00 | 21.00 | 21.00 | 21.00 | 21.00 |
Liabilities | 1.5% | 400 | 395 | 394 | 385 | 398 | 414 | 448 | 446 | 495 | 514 | 544 | 545 | 564 | 562 | 566 | 513 | 508 | 535 | 554 | 562 | 463 |
Current Liabilities | 4.8% | 214 | 205 | 198 | 183 | 198 | 210 | 224 | 216 | 263 | 258 | 273 | 266 | 281 | 260 | 262 | 218 | 195 | 181 | 172 | 170 | 158 |
Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 30.00 | 55.00 | 55.00 | 55.00 |
LT Debt, Current | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 50.00 | 10.00 | - | - | - | - |
LT Debt, Non Current | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 30.00 | 55.00 | 55.00 | 55.00 |
Shareholder's Equity | 2.7% | 909 | 885 | 886 | 880 | 874 | 881 | 903 | 911 | 908 | 902 | 913 | 810 | 798 | 777 | 769 | 743 | 779 | 772 | 760 | 751 | 734 |
Retained Earnings | 2.9% | 688 | 668 | 667 | 660 | 657 | 659 | 670 | 676 | 669 | 662 | 673 | 576 | 563 | 543 | 539 | 518 | 553 | 547 | 536 | 530 | 516 |
Additional Paid-In Capital | 0.3% | 228 | 227 | 226 | 225 | 227 | 229 | 234 | 233 | 232 | 231 | 230 | 227 | 227 | 226 | 225 | 224 | 223 | 221 | 221 | 220 | 219 |
Accumulated Depreciation | 0.7% | 608 | 604 | 595 | 585 | 575 | 565 | 561 | 553 | 543 | 541 | 530 | 520 | 510 | 511 | 503 | 492 | 482 | 471 | 465 | 455 | 444 |
Shares Outstanding | 0.2% | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 | - | - | - | - | - | - | - | - | - |
Minority Interest | -20.3% | 2.00 | 2.00 | 2.00 | 3.00 | 3.00 | 4.00 | 5.00 | 6.00 | 5.00 | 6.00 | 6.00 | 3.00 | 3.00 | 3.00 | 1.00 | 1.00 | 0.00 | 0.00 | 1.00 | 1.00 | 1.00 |
Float | - | - | - | 546 | - | - | - | 720 | - | - | - | 605 | - | - | - | 605 | - | - | - | 858 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | -20.3% | 25,733 | 32,305 | 39,321 | 13,857 | 11,934 | -1,977 | 26,242 | -27,457 | 15,523 | 6,749 | 27,533 | 12,589 | 19,359 | 29,173 | 146,973 | 7,754 | 25,219 | 35,712 | 27,571 | 11,601 | 21,369 |
Share Based Compensation | -6.4% | 663 | 708 | 772 | 639 | 632 | 639 | 629 | 712 | 715 | 726 | 683 | 496 | 646 | 518 | 823 | 466 | 430 | 340 | 684 | 424 | 240 |
Cashflow From Investing | -98.4% | -10,186 | -5,135 | -820 | -1,427 | 2,832 | -647 | -2,243 | -5,920 | -13,052 | -20,842 | -26,143 | -5,852 | -48,605 | 3,294 | -2,342 | -16,225 | -4,442 | 1,547 | -8,423 | -2,947 | -6,572 |
Cashflow From Financing | -0.1% | -9,834 | -9,820 | -10,272 | -12,619 | -12,101 | -16,744 | -8,347 | -10,450 | -9,495 | -9,727 | -6,894 | -9,148 | -8,370 | -7,128 | -58,032 | 31,641 | -27,849 | -35,083 | -7,941 | -8,875 | -27,610 |
Dividend Payments | 0.0% | 9,040 | 9,039 | 8,733 | 8,748 | 8,774 | 8,828 | 8,509 | 8,493 | 8,020 | 8,020 | 8,002 | 7,988 | 7,986 | 7,987 | 7,980 | 7,968 | 7,968 | 7,965 | 7,652 | 7,623 | 7,613 |
Buy Backs | - | - | - | - | 2,482 | 2,996 | 6,761 | - | 146 | 558 | - | - | 278 | - | - | - | 53.00 | - | - | - | 872 | - |
Consolidated Statements of Operations - USD ($) | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Revenues: | |||
Net patient revenues | $ 1,087,614,000 | $ 1,029,085,000 | $ 965,542,000 |
Other revenues | 53,930,000 | 45,196,000 | 45,400,000 |
Government stimulus income | 0 | 11,457,000 | 63,360,000 |
Net operating revenues and grant income | 1,141,544,000 | 1,085,738,000 | 1,074,302,000 |
Costs and Expenses: | |||
Salaries, wages and benefits | 712,344,000 | 686,169,000 | 666,063,000 |
Other operating | 288,183,000 | 289,372,000 | 266,754,000 |
Facility rent | 41,525,000 | 40,977,000 | 40,818,000 |
Depreciation and amortization | 42,034,000 | 40,489,000 | 40,672,000 |
Interest | 324,000 | 563,000 | 845,000 |
Impairment of assets | 0 | (3,728,000) | 8,225,000 |
Total costs and expenses | 1,084,410,000 | 1,053,842,000 | 1,023,377,000 |
Income from operations | 57,134,000 | 31,896,000 | 50,925,000 |
Other income: | |||
Non-operating income | 16,660,000 | 11,141,000 | 17,774,000 |
Gain on acquisition of equity method investment | 0 | 0 | 95,202,000 |
Unrealized gains on marketable equity securities | 14,944,000 | (15,806,000) | (13,863,000) |
Income before income taxes | 88,738,000 | 27,231,000 | 150,038,000 |
Income tax provision | (23,450,000) | (7,254,000) | (10,951,000) |
Net income | 65,288,000 | 19,977,000 | 139,087,000 |
Net (income) loss attributable to noncontrolling interest | 1,510,000 | 2,468,000 | (497,000) |
Net income attributable to National HealthCare Corporation | $ 66,798,000 | $ 22,445,000 | $ 138,590,000 |
Earnings per share attributable to National HealthCare Corporation stockholders: | |||
Basic (in dollars per share) | $ 4.36 | $ 1.46 | $ 9.03 |
Diluted (in dollars per share) | $ 4.34 | $ 1.45 | $ 8.99 |
Basic (in shares) | 15,310,142 | 15,410,222 | 15,347,129 |
Diluted (in shares) | 15,377,343 | 15,447,211 | 15,416,716 |
Dividends declared to common stockholders, per share (in dollars per share) | $ 2.34 | $ 2.26 | $ 2.11 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current Assets: | ||
Cash and cash equivalents | $ 107,076 | $ 58,667 |
Restricted cash and cash equivalents, current portion | 17,725 | 15,121 |
Marketable equity securities | 111,117 | 100,786 |
Marketable debt securities | 5,427 | 23,136 |
Restricted marketable equity securities | 26,779 | 22,358 |
Restricted marketable debt securities, current portion | 12,822 | 16,244 |
Accounts receivable | 108,545 | 99,986 |
Inventories | 7,386 | 7,088 |
Prepaid expenses and other assets | 8,855 | 10,244 |
Notes receivable | 503 | 302 |
Total current assets | 406,235 | 353,932 |
Property and Equipment: | ||
Property and equipment, at cost | 1,101,681 | 1,081,219 |
Accumulated depreciation and amortization | (608,352) | (574,687) |
Net property and equipment | 493,329 | 506,532 |
Other Assets: | ||
Restricted cash and cash equivalents, less current portion | 1,167 | 1,077 |
Restricted marketable debt securities, less current portion | 109,478 | 103,267 |
Deposits and other assets | 14,786 | 12,728 |
Operating lease – right-of-use assets | 94,201 | 120,521 |
Goodwill | 168,295 | 168,295 |
Intangible assets | 7,038 | 7,038 |
Investments in unconsolidated companies | 16,267 | 2,060 |
Total other assets | 411,232 | 414,986 |
Total assets | 1,310,796 | 1,275,450 |
Current Liabilities: | ||
Trade accounts payable | 19,194 | 16,958 |
Finance lease obligations, current portion | 860 | 4,985 |
Operating lease liabilities, current portion | 29,352 | 29,075 |
Accrued payroll | 84,110 | 72,510 |
Amounts due to third party payors | 18,369 | 16,631 |
Accrued risk reserves, current portion | 30,549 | 31,365 |
Other current liabilities | 22,991 | 17,615 |
Dividends payable | 9,051 | 8,748 |
Total current liabilities | 214,476 | 197,887 |
Finance lease obligations, less current portion | 0 | 860 |
Operating lease liabilities, less current portion | 63,175 | 91,016 |
Accrued risk reserves, less current portion | 72,710 | 71,104 |
Refundable entrance fees | 6,376 | 6,207 |
Deferred income taxes | 17,200 | 10,909 |
Other noncurrent liabilities | 26,379 | 19,953 |
Total liabilities | 400,316 | 397,936 |
Equity: | ||
Common stock, $.01 par value; 45,000,000 shares authorized; 15,350,661 and 15,357,746 shares, respectively, issued and outstanding | 153 | 153 |
Capital in excess of par value | 227,604 | 226,991 |
Retained earnings | 687,599 | 656,664 |
Accumulated other comprehensive loss | (6,604) | (9,532) |
Total National HealthCare Corporation stockholders’ equity | 908,752 | 874,276 |
Noncontrolling interest | 1,728 | 3,238 |
Total equity | 910,480 | 877,514 |
Total liabilities and equity | $ 1,310,796 | $ 1,275,450 |
 | Dr. Stephen Fowler Flatt |
---|---|
 | nhccare.com |
 | Healthcare Plans |
 | 12355 |